Nonalcoholic Steatohepatitis with Fibrosis
📧 Sign up to get email alerts when something new happens for Nonalcoholic Steatohepatitis with Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Disease [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluated the combination of dasatinib and quercetin for fibrotic non-alcoholic fatty liver disease (NA…
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) [Phase 3]
Phase 3 trial of elafibranor vs placebo in nonalcoholic steatohepatitis with fibrosis was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of JKB-122 in Patients With NASH and Fibrosis [Phase 2]
Phase 2 trial update for JKB-122 in nonalcoholic steatohepatitis with fibrosis to evaluate efficacy and safety.